News

The lawsuit covers Pronova BioPharma’s US patent no 7,732,488, US patent no. 7,678,930 and US patent no. 7,718,698. The patents entitled, ‘Pharmaceutical Composition Comprising Low Concentrations of Environmental

CHMP’s decision was backed by the positive results of a Phase III RADIANT-3 (RAD001 In Advanced Neuroendocrine Tumors) trial which demonstrated that the patients with advanced pancreatic NET

Sublinox, based on Orexo’s sublingual tablet technology is indicated as a short term treatment of insomnia. The tablet is a sublingual orally dissolving tablet that is placed under

A subsidiary of Glenmark Pharmaceuticals Limited India (GPL), GPSA’s GRC 15300 is an inhibitor of the TRPV3 and has demonstrated significant pharmacokinetic profile in the trial. The results

Dutasteride and tamsulosin hydrochloride capsules of Watson Pharma are the generic version of GSK‘s JALYN, which is used to treat symptomatic benign prostatic hyperplasia (BPH) in men suffering

The company plans to call for an end-of review meeting with the FDA to comprehend the details of the CRL and to discuss regarding further steps to be

The investment allows HBYS commercial team to also sell third party products in all provinces in China. HBYS will invest $3.2m for a 60% equity interest in NBHG

The lymph nodes are located using a radioactive signal with a hand-held radioactive tracer and are surgically removed and analyzed to determine if tumor cells are present. Clinical

Further, A*Star has chosen Agilent to offer automation technologies to biomedical researchers, enabling efficient drug screening in one location. A*STAR has now deployed Agilent’s dual BioCel 1200 integrated